SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

DELL is trending as traders analyze the stock's technical setup and overall sector sentiment ahead of its upcoming fiscal second-quarter earnings report. Market participants are debating whether recent price volatility constitutes a buying opportunity or a warning of further downside, with discussions heavily focused on Dell's role in the AI server infrastructure market.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The market is experiencing volatility driven by heightened tensions in the Middle East following U.S. strikes against Iranian targets, which has pushed oil prices and bond yields higher. While some traders are bracing for further downside, others are betting on a reversal, citing historical patterns where similar geopolitical news triggers brief dips followed by quick recoveries.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares experienced a significant rally following the transition of John Ternus to the CEO role and his positive internal memo regarding upcoming product launches. Investors are focused on the upcoming September 9 event, with some traders optimistic about the new leadership, while others express skepticism and view the price movement as a technical pump.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as traders react to escalating geopolitical tensions in the Middle East, specifically U.S. forces conducting strikes on Iranian targets near the Strait of Hormuz. While some investors are betting on further price surges due to supply chain disruptions, others are skeptical and focusing on potential diplomatic efforts or broader economic pressure as market catalysts.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is trending as retail traders react to a combination of geopolitical tensions in the Middle East and rising U.S. Treasury yields, which are fueling concerns about market stability. While some traders are bracing for a deeper correction, others emphasize the persistent resilience of the market to sustain prices despite these negative catalysts.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

The community is debating the potential for a short squeeze as Novavax shares face high short interest and investors look for catalysts following recent competitor developments in oncology vaccines. Discussions are primarily focused on the potential of the Matrix-M adjuvant platform to be utilized in cancer therapy and the hope for upcoming partnership announcements to drive price momentum.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

Fervo Energy is trending following a significant 396-megawatt power purchase agreement with Google, a development widely viewed by the community as a fundamental validation of the company's geothermal technology and its role in powering AI data centers. Traders are debating the stock's potential for a short squeeze and long-term valuation, with many optimistic about institutional demand while others caution against high dilution risk and the company's pre-revenue status.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending ahead of its upcoming earnings report, with the community expressing a mix of bullish sentiment regarding its role in the AI-driven cybersecurity boom and bearish concerns over its premium valuation. Traders are closely monitoring implied volatility and the potential for a volatile post-earnings move, referencing historical reaction statistics and ongoing sector rotation.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar, and sustainability. The company was founded on November 17, 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PCG and other California utility stocks experienced a significant decline following reports that state lawmakers failed to advance legislation providing protection against wildfire-related liabilities. Traders are expressing frustration over the volatility and uncertainty surrounding these regulatory risks, with some debating whether the sell-off represents a buying opportunity or a deeper issue.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology is trending as traders analyze the stock's volatility and positioning ahead of its upcoming earnings report, with sentiment divided between those viewing the pullback as a buying opportunity and others concerned about macro headwinds and customer concentration risks. Discussion is focused on whether the stock will break support or experience a post-earnings rebound driven by AI connectivity demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition?

Liquidia's Yutrepia is driving rapid growth, but fierce PAH competition and new pipeline therapies could challenge its momentum.

If You Invested $1000 In Insmed Stock 10 Years Ago, You Would Have This Much Today

Insmed (NASDAQ:INSM) has outperformed the market over the past 10 years by 10.74% on an annualized basis producing an average annual return of 24.29%. Currently, Insmed has a market capitalization of $26.34 billion.read more...

Liquidia vs. Insmed: Which Pulmonary Stock Has Better Prospects Now?

Liquidia's Yutrepia is driving strong growth, but Insmed's Brinsupri and broader pipeline could make it the better long-term pick.

Insmed to Present at September 2026 Investor Conferences

Insmed to Present at September 2026 Investor Conferences Insmed to Present at September 2026 Investor Conferences PR Newswire BRIDGEWATER, N.J., Aug. 26, 2026 BRIDGEWATER, N.J., Aug. 26, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company...

BRINSUPRI (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

BRINSUPRI (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease BRINSUPRI (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients...

Top Analyst Reports for Visa, Lam Research & Caterpillar

Visa's payments growth, Lam Research's AI-driven demand and Caterpillar's broad market momentum headline today's top analyst reports.

Insmed (INSM) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

$1000 Invested In Insmed 5 Years Ago Would Be Worth This Much Today

Insmed (NASDAQ:INSM) has outperformed the market over the past 5 years by 29.76% on an annualized basis producing an average annual return of 41.43%. Currently, Insmed has a market capitalization of $28.82 billion.read more...

What Insmed Stock's Premium Is Actually Buying

What Insmed Stock's Premium Is Actually Buying...

Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake

INSM tops Q2 revenue and earnings estimates as strong Brinsupri uptake drives a 34% stock jump and prompts sharply higher 2026 sales guidance.

• Reported GAAP EPS of -$0.06 up 96.47% YoY
• Reported revenue of $425.49M up 296.11% YoY
• Insmed raised its 2026 BRINSUPRI revenue guidance to a range of $1.25 billion to $1.40 billion and reiterated its 2026 ARIKAYCE revenue guidance of $450 million to $470 million for the company.

Insmed recorded a net loss of $13.2 million while experiencing increased operating expenses, alongside potential regulatory and policy uncertainties that may impact the future timing of international commercial product launches.

Insmed raised its peak revenue estimates to over $14 billion for its lead programs, supported by strong BRINSUPRI revenue growth and positive clinical data reinforcing the potential of its TPIP pipeline.

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insmed Inc

INSM Stock Dips In Extended Trading After Experimental Skin Disease Drug Fails In Study 

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.39	--	--	N/A
Q2 '26	-$0.69	-$0.06	91.35%	BEAT
Q1 '26	-$0.96	-$0.76	21.11%	BEAT
Q4 '25	-$1.07	-$1.54	-43.74%	MISSED
Q3 '25	-$1.33	-$1.75	-31.71%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings